UBS Group AG Has $2.72 Million Holdings in USANA Health Sciences, Inc. $USNA

UBS Group AG boosted its holdings in USANA Health Sciences, Inc. (NYSE:USNA) by 252.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 138,334 shares of the company’s stock after buying an additional 99,063 shares during the quarter. UBS Group AG owned approximately 0.76% of USANA Health Sciences worth $2,715,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of USNA. National Bank of Canada FI boosted its stake in USANA Health Sciences by 166.6% in the third quarter. National Bank of Canada FI now owns 1,922 shares of the company’s stock valued at $53,000 after buying an additional 1,201 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in USANA Health Sciences by 382.5% in the second quarter. Tower Research Capital LLC TRC now owns 2,398 shares of the company’s stock valued at $73,000 after buying an additional 1,901 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in USANA Health Sciences by 52.9% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,834 shares of the company’s stock valued at $106,000 after buying an additional 1,327 shares in the last quarter. iSAM Funds UK Ltd acquired a new stake in USANA Health Sciences in the third quarter valued at about $120,000. Finally, Quantbot Technologies LP boosted its stake in USANA Health Sciences by 19.5% in the second quarter. Quantbot Technologies LP now owns 3,957 shares of the company’s stock valued at $121,000 after buying an additional 646 shares in the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Trading Down 1.9%

Shares of USNA stock opened at $18.38 on Wednesday. The business’s 50-day moving average price is $18.24 and its 200-day moving average price is $19.48. USANA Health Sciences, Inc. has a 12 month low of $16.60 and a 12 month high of $38.32. The firm has a market capitalization of $339.35 million, a price-to-earnings ratio of 39.11, a PEG ratio of 0.74 and a beta of 0.77.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.44 by $0.17. USANA Health Sciences had a return on equity of 6.21% and a net margin of 0.96%.The firm had revenue of $250.22 million for the quarter, compared to analyst estimates of $240.99 million. USANA Health Sciences has set its FY 2026 guidance at 1.950-2.290 EPS. On average, sell-side analysts predict that USANA Health Sciences, Inc. will post 2.12 earnings per share for the current fiscal year.

Analyst Ratings Changes

USNA has been the topic of several research analyst reports. Wall Street Zen lowered USANA Health Sciences from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Weiss Ratings reaffirmed a “sell (d)” rating on shares of USANA Health Sciences in a research note on Friday, March 27th. Finally, Zacks Research lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Reduce”.

Insider Activity at USANA Health Sciences

In other news, insider Joshua Foukas sold 3,791 shares of USANA Health Sciences stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $19.82, for a total transaction of $75,137.62. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders sold 5,906 shares of company stock worth $112,847 over the last quarter. Company insiders own 0.82% of the company’s stock.

USANA Health Sciences Profile

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.